0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Haemophilia Treatment Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-36J7207
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Haemophilia Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Haemophilia Treatment Market Research Report 2024

Code: QYRE-Auto-36J7207
Report
January 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Haemophilia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Haemophilia Treatment Market

Haemophilia Treatment Market

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.
The global Haemophilia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Haemophilia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemophilia Treatment.

Report Scope

The Haemophilia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Haemophilia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Haemophilia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Haemophilia Treatment Market Report

Report Metric Details
Report Name Haemophilia Treatment Market
CAGR 5%
Segment by Type
  • Haemophilia A
  • Haemophilia B
Segment by Application
  • Hospital
  • Pharmaceutical Companies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda, CSL Behring, Alnylam Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Haemophilia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Haemophilia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilia Treatment Market report?

Ans: The main players in the Haemophilia Treatment Market are Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda, CSL Behring, Alnylam Pharmaceuticals

What are the Application segmentation covered in the Haemophilia Treatment Market report?

Ans: The Applications covered in the Haemophilia Treatment Market report are Hospital, Pharmaceutical Companies, Other

What are the Type segmentation covered in the Haemophilia Treatment Market report?

Ans: The Types covered in the Haemophilia Treatment Market report are Haemophilia A, Haemophilia B

1 Haemophilia Treatment Market Overview
1.1 Product Overview and Scope of Haemophilia Treatment
1.2 Haemophilia Treatment Segment by Type
1.2.1 Global Haemophilia Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Haemophilia Treatment Segment by Application
1.3.1 Global Haemophilia Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Haemophilia Treatment Market Size Estimates and Forecasts
1.4.1 Global Haemophilia Treatment Revenue 2019-2030
1.4.2 Global Haemophilia Treatment Sales 2019-2030
1.4.3 Global Haemophilia Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Haemophilia Treatment Market Competition by Manufacturers
2.1 Global Haemophilia Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Haemophilia Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Haemophilia Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Haemophilia Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Haemophilia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Haemophilia Treatment, Product Type & Application
2.7 Haemophilia Treatment Market Competitive Situation and Trends
2.7.1 Haemophilia Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Haemophilia Treatment Players Market Share by Revenue
2.7.3 Global Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Haemophilia Treatment Retrospective Market Scenario by Region
3.1 Global Haemophilia Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Haemophilia Treatment Global Haemophilia Treatment Sales by Region: 2019-2030
3.2.1 Global Haemophilia Treatment Sales by Region: 2019-2024
3.2.2 Global Haemophilia Treatment Sales by Region: 2025-2030
3.3 Global Haemophilia Treatment Global Haemophilia Treatment Revenue by Region: 2019-2030
3.3.1 Global Haemophilia Treatment Revenue by Region: 2019-2024
3.3.2 Global Haemophilia Treatment Revenue by Region: 2025-2030
3.4 North America Haemophilia Treatment Market Facts & Figures by Country
3.4.1 North America Haemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Haemophilia Treatment Sales by Country (2019-2030)
3.4.3 North America Haemophilia Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Haemophilia Treatment Market Facts & Figures by Country
3.5.1 Europe Haemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Haemophilia Treatment Sales by Country (2019-2030)
3.5.3 Europe Haemophilia Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Haemophilia Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Haemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Haemophilia Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Haemophilia Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Haemophilia Treatment Market Facts & Figures by Country
3.7.1 Latin America Haemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Haemophilia Treatment Sales by Country (2019-2030)
3.7.3 Latin America Haemophilia Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Haemophilia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Haemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Haemophilia Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Haemophilia Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Haemophilia Treatment Sales by Type (2019-2030)
4.1.1 Global Haemophilia Treatment Sales by Type (2019-2024)
4.1.2 Global Haemophilia Treatment Sales by Type (2025-2030)
4.1.3 Global Haemophilia Treatment Sales Market Share by Type (2019-2030)
4.2 Global Haemophilia Treatment Revenue by Type (2019-2030)
4.2.1 Global Haemophilia Treatment Revenue by Type (2019-2024)
4.2.2 Global Haemophilia Treatment Revenue by Type (2025-2030)
4.2.3 Global Haemophilia Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Haemophilia Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Haemophilia Treatment Sales by Application (2019-2030)
5.1.1 Global Haemophilia Treatment Sales by Application (2019-2024)
5.1.2 Global Haemophilia Treatment Sales by Application (2025-2030)
5.1.3 Global Haemophilia Treatment Sales Market Share by Application (2019-2030)
5.2 Global Haemophilia Treatment Revenue by Application (2019-2030)
5.2.1 Global Haemophilia Treatment Revenue by Application (2019-2024)
5.2.2 Global Haemophilia Treatment Revenue by Application (2025-2030)
5.2.3 Global Haemophilia Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Haemophilia Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Haemophilia Treatment Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novo Nordisk Haemophilia Treatment Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Haemophilia Treatment Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Haemophilia Treatment Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Aptevo Therapeutics
6.5.1 Aptevo Therapeutics Corporation Information
6.5.2 Aptevo Therapeutics Description and Business Overview
6.5.3 Aptevo Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aptevo Therapeutics Haemophilia Treatment Product Portfolio
6.5.5 Aptevo Therapeutics Recent Developments/Updates
6.6 Catalyst BioSciences
6.6.1 Catalyst BioSciences Corporation Information
6.6.2 Catalyst BioSciences Description and Business Overview
6.6.3 Catalyst BioSciences Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Catalyst BioSciences Haemophilia Treatment Product Portfolio
6.6.5 Catalyst BioSciences Recent Developments/Updates
6.7 Dimension Therapeutics
6.6.1 Dimension Therapeutics Corporation Information
6.6.2 Dimension Therapeutics Description and Business Overview
6.6.3 Dimension Therapeutics Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dimension Therapeutics Haemophilia Treatment Product Portfolio
6.7.5 Dimension Therapeutics Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Takeda Haemophilia Treatment Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 CSL Behring
6.9.1 CSL Behring Corporation Information
6.9.2 CSL Behring Description and Business Overview
6.9.3 CSL Behring Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Behring Haemophilia Treatment Product Portfolio
6.9.5 CSL Behring Recent Developments/Updates
6.10 Alnylam Pharmaceuticals
6.10.1 Alnylam Pharmaceuticals Corporation Information
6.10.2 Alnylam Pharmaceuticals Description and Business Overview
6.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Product Portfolio
6.10.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Haemophilia Treatment Industry Chain Analysis
7.2 Haemophilia Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Haemophilia Treatment Production Mode & Process
7.4 Haemophilia Treatment Sales and Marketing
7.4.1 Haemophilia Treatment Sales Channels
7.4.2 Haemophilia Treatment Distributors
7.5 Haemophilia Treatment Customers
8 Haemophilia Treatment Market Dynamics
8.1 Haemophilia Treatment Industry Trends
8.2 Haemophilia Treatment Market Drivers
8.3 Haemophilia Treatment Market Challenges
8.4 Haemophilia Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Haemophilia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Haemophilia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Haemophilia Treatment Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Haemophilia Treatment Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Haemophilia Treatment Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Haemophilia Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Haemophilia Treatment Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Haemophilia Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Haemophilia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Haemophilia Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Haemophilia Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of Haemophilia Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Haemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Treatment as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Haemophilia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Haemophilia Treatment Sales by Region (2019-2024) & (K Units)
    Table 18. Global Haemophilia Treatment Sales Market Share by Region (2019-2024)
    Table 19. Global Haemophilia Treatment Sales by Region (2025-2030) & (K Units)
    Table 20. Global Haemophilia Treatment Sales Market Share by Region (2025-2030)
    Table 21. Global Haemophilia Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Haemophilia Treatment Revenue Market Share by Region (2019-2024)
    Table 23. Global Haemophilia Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Haemophilia Treatment Revenue Market Share by Region (2025-2030)
    Table 25. North America Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Haemophilia Treatment Sales by Country (2019-2024) & (K Units)
    Table 27. North America Haemophilia Treatment Sales by Country (2025-2030) & (K Units)
    Table 28. North America Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Haemophilia Treatment Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Haemophilia Treatment Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Haemophilia Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Haemophilia Treatment Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Haemophilia Treatment Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Haemophilia Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Haemophilia Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Haemophilia Treatment Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Haemophilia Treatment Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Haemophilia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Haemophilia Treatment Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Haemophilia Treatment Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Haemophilia Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Haemophilia Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Haemophilia Treatment Sales (K Units) by Type (2019-2024)
    Table 51. Global Haemophilia Treatment Sales (K Units) by Type (2025-2030)
    Table 52. Global Haemophilia Treatment Sales Market Share by Type (2019-2024)
    Table 53. Global Haemophilia Treatment Sales Market Share by Type (2025-2030)
    Table 54. Global Haemophilia Treatment Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Haemophilia Treatment Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Haemophilia Treatment Revenue Market Share by Type (2019-2024)
    Table 57. Global Haemophilia Treatment Revenue Market Share by Type (2025-2030)
    Table 58. Global Haemophilia Treatment Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Haemophilia Treatment Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Haemophilia Treatment Sales (K Units) by Application (2019-2024)
    Table 61. Global Haemophilia Treatment Sales (K Units) by Application (2025-2030)
    Table 62. Global Haemophilia Treatment Sales Market Share by Application (2019-2024)
    Table 63. Global Haemophilia Treatment Sales Market Share by Application (2025-2030)
    Table 64. Global Haemophilia Treatment Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Haemophilia Treatment Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Haemophilia Treatment Revenue Market Share by Application (2019-2024)
    Table 67. Global Haemophilia Treatment Revenue Market Share by Application (2025-2030)
    Table 68. Global Haemophilia Treatment Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Haemophilia Treatment Price (USD/Unit) by Application (2025-2030)
    Table 70. Bayer Corporation Information
    Table 71. Bayer Description and Business Overview
    Table 72. Bayer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Bayer Haemophilia Treatment Product
    Table 74. Bayer Recent Developments/Updates
    Table 75. Novo Nordisk Corporation Information
    Table 76. Novo Nordisk Description and Business Overview
    Table 77. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Novo Nordisk Haemophilia Treatment Product
    Table 79. Novo Nordisk Recent Developments/Updates
    Table 80. Pfizer Corporation Information
    Table 81. Pfizer Description and Business Overview
    Table 82. Pfizer Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Pfizer Haemophilia Treatment Product
    Table 84. Pfizer Recent Developments/Updates
    Table 85. Roche Corporation Information
    Table 86. Roche Description and Business Overview
    Table 87. Roche Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Roche Haemophilia Treatment Product
    Table 89. Roche Recent Developments/Updates
    Table 90. Aptevo Therapeutics Corporation Information
    Table 91. Aptevo Therapeutics Description and Business Overview
    Table 92. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Aptevo Therapeutics Haemophilia Treatment Product
    Table 94. Aptevo Therapeutics Recent Developments/Updates
    Table 95. Catalyst BioSciences Corporation Information
    Table 96. Catalyst BioSciences Description and Business Overview
    Table 97. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Catalyst BioSciences Haemophilia Treatment Product
    Table 99. Catalyst BioSciences Recent Developments/Updates
    Table 100. Dimension Therapeutics Corporation Information
    Table 101. Dimension Therapeutics Description and Business Overview
    Table 102. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Dimension Therapeutics Haemophilia Treatment Product
    Table 104. Dimension Therapeutics Recent Developments/Updates
    Table 105. Takeda Corporation Information
    Table 106. Takeda Description and Business Overview
    Table 107. Takeda Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Takeda Haemophilia Treatment Product
    Table 109. Takeda Recent Developments/Updates
    Table 110. CSL Behring Corporation Information
    Table 111. CSL Behring Description and Business Overview
    Table 112. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. CSL Behring Haemophilia Treatment Product
    Table 114. CSL Behring Recent Developments/Updates
    Table 115. Alnylam Pharmaceuticals Corporation Information
    Table 116. Alnylam Pharmaceuticals Description and Business Overview
    Table 117. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Alnylam Pharmaceuticals Haemophilia Treatment Product
    Table 119. Alnylam Pharmaceuticals Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Haemophilia Treatment Distributors List
    Table 123. Haemophilia Treatment Customers List
    Table 124. Haemophilia Treatment Market Trends
    Table 125. Haemophilia Treatment Market Drivers
    Table 126. Haemophilia Treatment Market Challenges
    Table 127. Haemophilia Treatment Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Haemophilia Treatment
    Figure 2. Global Haemophilia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Haemophilia Treatment Market Share by Type in 2023 & 2030
    Figure 4. Haemophilia A Product Picture
    Figure 5. Haemophilia B Product Picture
    Figure 6. Global Haemophilia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Haemophilia Treatment Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Pharmaceutical Companies
    Figure 10. Other
    Figure 11. Global Haemophilia Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Haemophilia Treatment Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Haemophilia Treatment Sales (2019-2030) & (K Units)
    Figure 14. Global Haemophilia Treatment Average Price (USD/Unit) & (2019-2030)
    Figure 15. Haemophilia Treatment Report Years Considered
    Figure 16. Haemophilia Treatment Sales Share by Manufacturers in 2023
    Figure 17. Global Haemophilia Treatment Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Haemophilia Treatment Players: Market Share by Revenue in 2023
    Figure 19. Haemophilia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Haemophilia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Haemophilia Treatment Sales Market Share by Country (2019-2030)
    Figure 22. North America Haemophilia Treatment Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Haemophilia Treatment Sales Market Share by Country (2019-2030)
    Figure 26. Europe Haemophilia Treatment Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Haemophilia Treatment Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Haemophilia Treatment Revenue Market Share by Region (2019-2030)
    Figure 34. China Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Haemophilia Treatment Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Haemophilia Treatment Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Haemophilia Treatment Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Haemophilia Treatment Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Haemophilia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Haemophilia Treatment by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Haemophilia Treatment by Type (2019-2030)
    Figure 56. Global Haemophilia Treatment Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Haemophilia Treatment by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Haemophilia Treatment by Application (2019-2030)
    Figure 59. Global Haemophilia Treatment Price (USD/Unit) by Application (2019-2030)
    Figure 60. Haemophilia Treatment Value Chain
    Figure 61. Haemophilia Treatment Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Oculopharyngeal Muscular Dystrophy (OPMD) Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20M15561
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Genetic Disease Diagnosis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11V13013
Wed Jun 12 00:00:00 UTC 2024

Add to Cart

Global Down Syndrome Diagnosis and Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9N13396
Thu May 30 00:00:00 UTC 2024

Add to Cart

Global Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33T12992
Thu May 30 00:00:00 UTC 2024

Add to Cart